IL22 and infection: Our data suggest that IL-22 induced by orally fed BLS-mix not only acts on the intestine to maintain the mucosal homeostasis [9], it also promotes an inflammatory response in inflamed intestinal mucosal tissues as a result of infection with enteropathogenic bacteria.